stockrowWaystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) EV/Sales
As of 5 November 2026, Waystar Holding Corp. (WAY) trades at a EV/Sales of 5.3×. Over the past ten years it has ranged from 0.0× (June 2024) to 8.5× (December 2024); the current reading is higher than 34% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.5× | (5.54%) |
| FY2024 | 6.9× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 4.8× | 11.06% |
| Jun 2026 | 4.3× | (15.80%) |
| Mar 2026 | 5.1× | (22.06%) |
| Dec 2025 | 6.5× | (8.02%) |
| 9 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| PRVA Privia Health Group, Inc. compare | 1.1× |
| WAY Waystar Holding Corp. | 5.3× |
| SDGR Schrodinger, Inc. compare | 6.7× |
| HQY HealthEquity, Inc. compare | 6.8× |
| DOCS Doximity, Inc. compare | 7.9× |
| TEM Tempus AI, Inc. compare | 8.9× |
| HNGE Hinge Health Inc. compare | 12.2× |
| HTFL Heartflow, Inc. compare | 21.4× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement